Immunotech Laboratories ( OTCPK:IMMB -16.7% ) completes Phase 1 and Phase 2 trials of its HIV/AIDS and Hepatitis C virus treatment ( ITV-1 ) in Bulgaria. It has also completed toxicity testing and pharmacokinetic analyses on animals. The firm is preparing its application for a permit to proceed to
(Adds analyst comment, background; updates share movement)
Aug 15 (Reuters) - Gilead Sciences Inc said an arbitration panel has ruled in its favor, rejecting patent infringement claims from Roche Holding AG, related to Gilead's hepatitis C drug, Sovaldi.
ARC-520 is being studied as a functional cure for hepatitis B ( Hep B). The compound showed great promise in pre-clinical proof ..... a Phase 2a efficacy and escalating dosing study with chronic Hep B patients in March of 2014 and completed earlier this summer
Holly Energy Partners reported second-quarter results on Aug. 5 that fell short of expectations, primarily due to decreased throughput volumes on
board and chairman and CEO of Holly Energy Partners L.P. Mike Jennings, CEO ..... has a 39% ownership stake in Holly Energy Partners , which owns and operates petroleum ..... the value in the ownership of HEP . Our fair value estimate implies
Holly Energy Partners , L.P. (NYSE: HEP ): Q2 EPS of $0.25 misses by $0.05 . Revenue of $75M (-0.4% Y/Y) misses by $5.11M . Press Release Post your comment!
CLDT , CNK , COH , CRZO , CVC , CVS , DWRE , EMR , END , ENZY , EXH , EXLP , EXPD , FE , FUN , GLDD , GTIV , GTXI , HCLP , HCP , HEP , IART , IFF , IIVI , INFI , IT , KWK , LIN , LPX , MDU , MGM , MMP , MSI , MWW , MZOR , NILE , NNN , [[NTi]], NVDQ , NWN
less flat demand. Holly Energy Partners operates a network ..... HollyFrontier, formed HEP in 2004 to acquire ..... strategic relationship. HEP also faces pipeline ..... value estimate for Holly Energy Partners to $34 per unit from ..... yield of 5.9%. In HEP 's domestic pipelines
our MLP coverage, we rate only three other stocks as low uncertainty-- Magellan Midstream Partners MMP, Holly Energy Partners HEP , and Spectra Energy Partners. We continue to believe that these three partnerships exhibit stable, predictable